UPDATE 1-Sanofi blood disorder drug wins FDA approval

The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Sanofi SA's drug to treat a rare blood-clotting disorder in adults in combination with standard-of-care treatments.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.